Physician profile
Larry E Gray
NPI 1326090069
$565.51
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $270 · 2020: $48.54 · 2021: $117 · 2022: $74.71 · 2023: $17.91 · 2024: $37.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $55.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $55.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $187.21 | 2019 | |
| Glaxosmithkline, LLC. | $79.92 | 2019-2022 | |
| Cranial Technologies, INC | $49.61 | 2021-2022 | |
| Genentech USA, INC. | $48.74 | 2019-2020 | |
| Adlon Therapeutics L.P. | $46.34 | 2021 | |
| Corium, LLC | $39.31 | 2022-2024 | Azstarys |
| Sobi, INC | $26.14 | 2019 | |
| Neos Therapeutics, LP | $18.51 | 2019 | |
| Sanofi Pasteur INC. | $18.33 | 2022 | |
| Pfizer INC. | $17.91 | 2023 | |
| Tris Pharma INC | $17.83 | 2024 | Dyanavel Xr |
| Merck Sharp & Dohme LLC | $15.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Gray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.